Sindy Liao-Chan

Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs

Christopher R. Behrens, Edward Ha, Lawrence Chinn et al. · Molecular Pharmaceutics · 2015 · 150 citations · Full text

Afford Adcs, Immunology, Immunotherapeutics +19

Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab

Sherman M. Chin, Christopher R. Kimberlin, Zygy Roe-Žurž et al. · Nature Communications · 2018 · 143 citations · Full text

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers

Edurne Rujas, Iga Kucharska, Yong Zi Tan et al. · Nature Communications · 2021 · 75 citations · Full text

IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity

Kelly D. Moynihan, Manu P. Kumar, Hussein Sultan et al. · Cancer Discovery · 2024 · 46 citations · Full text

CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma.

Gregory M. Hayes, Belinda Cairns, Zoia Levashova et al. · PubMed · 2015 · 42 citations · Full text

Tumor Biology, Cd39 Nucleotidase Activity, Soft Tissue Sarcoma +11